MedTrace Logo

An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

NCT07217977 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2026-05-06

No results posted yet for this study

Summary

The current study will investigate if QbMobile can be used to improve the accuracy and objective identification of reduced ADHD symptoms in tests scores once treatment has been initiated.

Conditions

  • Attention Deficit Disorder With Hyperactivity (ADHD)
  • Attention Deficit Disorder (ADD)

Interventions

OTHER

observational study

observational study

Sponsors & Collaborators

  • Qbtech AB

    lead INDUSTRY

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-15
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07217977 on ClinicalTrials.gov